dpx-survivac
Vaccineexperimental
Clinical trial activity
10 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01416038)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 1
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Ovarian Epithelial · Phase 1
- Fallopian Tube Neoplasms · Phase 2
- Hamartoma · Phase 2
- Lymphoma, Large B-Cell, Diffuse · Phase 2
- Microsatellite Instability · Phase 2
- Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 2
- Urinary Bladder Neoplasms · Phase 2
Mechanism of action
- Baculoviral IAP repeat-containing protein 5Immunity, active
BIRC5 immunity, active
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594319 ↗
Also known as
- dpx-survivac
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05243524 | Phase 2 | Aug 5, 2022 | ImmunoVaccine Technologies, Inc. |
| NCT04895761 | Phase 1 | Sep 10, 2021 | Providence Health & Services |
| NCT04920617 | Phase 2 | Jun 18, 2021 | ImmunoVaccine Technologies, Inc., Merck |
| NCT03836352 | Phase 2 | Dec 21, 2018 | ImmunoVaccine Technologies, Inc., Merck |
| NCT03349450 | Phase 2 | Mar 13, 2018 | ImmunoVaccine Technologies, Inc., Merck, University of Toronto |
| NCT03029403 | Phase 2 | Mar 13, 2017 | ImmunoVaccine Technologies, Inc., Merck, University of Toronto |
| NCT02785250 | Phase 1 | Apr 1, 2016 | ImmunoVaccine Technologies, Inc., Incyte |
| NCT02323230 | Phase 2 | Jan 1, 2015 | ImmunoVaccine Technologies, Inc. |
| NCT03332576 | Phase 1 | Aug 23, 2013 | ImmunoVaccine Technologies, Inc. |
| NCT01416038 | Phase 1 | Dec 1, 2011 | ImmunoVaccine Technologies, Inc. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImmunoVaccine Technologies, Inc. | For profit | 9 | 7 | 2 | 2011 |
| Merck | For profit | 4 | 0 | 1 | 2017 |
| University of Toronto | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Incyte | For profit | 1 | 0 | 1 | 2016 |
| Providence Health & Services | Academic/Hospital | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1